A Sectoral Analysis of the Indian Pharmaceutical Industry Using Dupont Analysis

Abstract

The pharmaceutical sector in India plays a pivotal role in healthcare both domestically and globally. Known as the "Pharmacy of the World," India supplies over 50% of the global demand for various vaccines, approximately 40% of the generic demand in the United States, and a significant portion of medicines required in developing nations. India also accounts for 70% of WHO’s vaccines (as per the essential Immunization schedule) and is a leading supplier of DPT, BCG and Measles vaccines. According to Invest India, the pharmaceutical industry in India is currently valued at $50 Bn and recorded a turnover of INR 4,17,345 Cr in 2023-24, a growth of 10% over 2022-23.